Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 606-239-2 | CAS number: 19130-96-2
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Desoxynojirimycin was shown to be not mutagenic with and without metabolic activation in a bacterial reverse mutation assay with the S. typhimurium strains TA 1535, TA 100, TA 1537 and TA 98.
The study was conducted using concentrations from 20 to 12500 µg per plate. Doses up to and including 100 µg/plate did not cause any bacteriotoxic effects. Higher doses had a weak bacteriotoxic effect, specific to strain, and could therefore nevertheless be used for evaluation up to and including 12500 µg/plate.
Short description of key information:
Gene mutation in vitro (bacterial reverse mutation assay, GLP, Richtlinie 84/449 EWG, B.14): negative in all tested Salmonella typhimurium strains
[Bayer AG, Report No. PH 16914, 1988-07-18]
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Classification according to Directive 67/548/EEC and Regulation (EC) No. 1272/2008 (CLP) is not required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
